8-117819743-AGGG-AGGGG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000127.3(EXT1):c.1468dupC(p.Leu490fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 32)
Consequence
EXT1
NM_000127.3 frameshift
NM_000127.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.06
Genes affected
EXT1 (HGNC:3512): (exostosin glycosyltransferase 1) This gene encodes an endoplasmic reticulum-resident type II transmembrane glycosyltransferase involved in the chain elongation step of heparan sulfate biosynthesis. Mutations in this gene cause the type I form of multiple exostoses. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-117819743-A-AG is Pathogenic according to our data. Variant chr8-117819743-A-AG is described in ClinVar as [Pathogenic]. Clinvar id is 279804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EXT1 | NM_000127.3 | c.1468dupC | p.Leu490fs | frameshift_variant | 6/11 | ENST00000378204.7 | NP_000118.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EXT1 | ENST00000378204.7 | c.1468dupC | p.Leu490fs | frameshift_variant | 6/11 | 1 | NM_000127.3 | ENSP00000367446.3 | ||
EXT1 | ENST00000437196.1 | n.*359dupC | non_coding_transcript_exon_variant | 5/10 | 5 | ENSP00000407299.1 | ||||
EXT1 | ENST00000684189.1 | n.935dupC | non_coding_transcript_exon_variant | 6/11 | ||||||
EXT1 | ENST00000437196.1 | n.*359dupC | 3_prime_UTR_variant | 5/10 | 5 | ENSP00000407299.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Multiple congenital exostosis Pathogenic:2
Pathogenic, flagged submission | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Mar 22, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 20, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 279804). This variant is also known as c.1468insC, c.1469insC, and c.1468-1469insC. This premature translational stop signal has been observed in individuals with multiple osteochondromas (PMID: 11170095, 15586175, 17301954, 18165274). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Leu490Profs*31) in the EXT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EXT1 are known to be pathogenic (PMID: 10679937, 11391482, 19810120). - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 08, 2018 | This variant has been reported previously in association with hereditary multiple exostoses (Wells et al., 1997; Seki et al., 2001; Signori et al., 2007). The c.1468dupC variant causes a frameshift starting with codon Leucine 490, changes this amino acid to a Proline residue and creates a premature Stop codon at position 31 of the new reading frame, denoted p.Leu490ProfsX31. The duplication follows a polycytosine tract which is a hot spot for pathogenic variants. Frameshift variants starting from codon Leucine 490 have been observed in 7% of patients with an EXT1-related disorder (Jennes et al., 2009). The c.1468dupC variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense mediated mRNA decay. - |
Pathogenic, criteria provided, single submitter | clinical testing | Al Jalila Children’s Genomics Center, Al Jalila Childrens Speciality Hospital | Dec 17, 2022 | - - |
Chondrosarcoma;CN263289:Exostoses, multiple, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Aug 20, 2021 | - - |
Exostoses, multiple, type 1 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The frameshift duplication p.L490Pfs*31 in EXT1 (NM_000127.3) has been reported previously in individuals affected with Hereditary multiple exostoses (Seki et al, 2001; Signori et al, 2007). This variant causes a frameshift starting with codon Leucine 490, changes this amino acid to Proline residue, and creates a premature Stop codon at position 31 of the new reading frame, denoted p.Leu490ProfsTer31. The p.L490Pfs*31 variant is novel (not in any individuals) in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. This variant is predicted to cause loss of normal protein function through protein truncation caused a frameshift mutation. The frame shifted sequence continues 31 residues until a stop codon is reached. The p.L490Pfs*31 variant is a loss of function variant in the gene EXT1, which is intolerant of Loss of Function variants. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at